Description: Auxergen, a Qualified Maryland Biotechnology Company, offers innovative biocontrol solutions for a sustainable future. Explore investment opportunities with Auxergen and benefit from tax incentives while driving biotechnological advancement.
cellular (259) microscopy (206) sars-cov-2 (185) lambda (88) cell biology (85) cell culture (70) immunofluorescence (7) human diseases (3) live cell-imaging cell-based assays vision biology
Auxergen creates and sells innovative biocontrol solutions that tackle diseases impacting humans, plants, and the environment; our mission is to substantially reduce the chemical strain on our soils and waterways.
Recognized as a Qualified Maryland Biotechnology Company by the Maryland Department of Commerce, we are one of the most widely published companies in ag-bio in America and foster a fertile ground for biotechnological advancements. Maryland has recognized our value year after year as a QMBC, enabling our investors to receive tax incentives for investing in Auxergen and, thereby, propelling Maryland towards a more prosperous, sustainable future.
Mission To reduce the use of chemical pesticides in agriculture, to reduce toxic runoff and to promote watershed and environmental health. To search for novel applications of discoveries at the nexus of human, animal and plant diseases.